Literature DB >> 17848293

Matching intensity-modulated radiation therapy to an anterior low neck field.

Robert J Amdur1, Chihray Liu, Jonathan Li, William Mendenhall, Russell Hinerman.   

Abstract

When using intensity-modulated radiation therapy (IMRT) to treat head and neck cancer with the primary site above the level of the larynx, there are two basic options for the low neck lymphatics: to treat the entire neck with IMRT, or to match the IMRT plan to a conventional anterior "low neck" field. In view of the potential advantages of using a conventional low neck field, it is important to look for ways to minimize or manage the problems of matching IMRT to a conventional radiotherapy field. Treating the low neck with a single anterior field and the standard larynx block decreases the dose to the larynx and often results in a superior IMRT plan at the primary site. The purpose of this article is to review the most applicable studies and to discuss our experience with implementing a technique that involves moving the position of the superior border of the low neck field several times during a single treatment fraction.

Entities:  

Mesh:

Year:  2007        PMID: 17848293     DOI: 10.1016/j.ijrobp.2007.04.091

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.

Authors:  Aruna Turaka; Tianyu Li; Nicos Nicolaou; Miriam N Lango; Barbara Burtness; Eric M Horwitz; John A Ridge; Steven J Feigenberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-10       Impact factor: 7.038

2.  Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma.

Authors:  Jin-Beom Chung; Jeong-Woo Lee; Jae-Sung Kim; In-Ah Kim; Doo-Hyun Lee; Yon-Lae Kim; Kyoung-Sik Choi; Bo-Young Choe; Tae-Suk Suh
Journal:  Radiol Phys Technol       Date:  2011-05-10

3.  Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.

Authors:  Tamer Refaat; Mehee Choi; Tarita O Thomas; Ian Bacchus; Mark Agulnik; Harold J Pelzer; Ann L Mellott; Alfred W Rademaker; Dachao Liu; Vythialinga Sathiaseelan; Bharat B Mittal
Journal:  Am J Clin Oncol       Date:  2015-12       Impact factor: 2.339

4.  Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging.

Authors:  Charles A Baron; Musaddiq J Awan; Abdallah S R Mohamed; Imad Akel; David I Rosenthal; G Brandon Gunn; Adam S Garden; Brandon A Dyer; Laurence Court; Parag R Sevak; Esengul Kocak-Uzel; Clifton D Fuller
Journal:  J Appl Clin Med Phys       Date:  2014-01-08       Impact factor: 2.102

5.  An opposed matched field IMRT technique for prostate cancer patients with bilateral prosthetic hips.

Authors:  Shahin Fattahi; Orest Z Ostapiak
Journal:  J Appl Clin Med Phys       Date:  2012-01-05       Impact factor: 2.102

6.  Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT.

Authors:  Christopher Wilke; Vinita Takiar; He Wang; Amy C Moreno; Shih-Ming Samuel Tung; Sean R Quinlan-Davidson; Adam S Garden; David I Rosenthal; Clifton D Fuller; Gary B Gunn; Jay P Reddy; William H Morrison; Congjun Wang; George Zhao; Katherine A Hutcheson; Jack Phan
Journal:  J Appl Clin Med Phys       Date:  2020-12-05       Impact factor: 2.102

7.  Feasibility of Tomotherapy-based image-guided radiotherapy to reduce aspiration risk in patients with non-laryngeal and non-pharyngeal head and neck cancer.

Authors:  Nam P Nguyen; Lexie Smith-Raymond; Vincent Vinh-Hung; Paul Vos; Rick Davis; Anand Desai; Thomas Sroka; Dave Abraham; Shane P Krafft; Michelle Stevie; Homayoun Modarresifar; Beng-Hoey Jo; Misty Ceizyk
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

8.  Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.

Authors:  Vishruta A Dumane; Richard Bakst; Sheryl Green
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.